Submitted by Anonymous (not verified) on 14 October 2025 - 16:18
Opinion/decision on a Paediatric investigation plan (PIP): Isturisa, Osilodrostat, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Endocrine disorders, PIP number: P/0325/2024
Source: